Latest update:
Tuesday, February 5, 2019 - 13:05
Sopharma AD (3JR: “BSE-Sofia” AD, SPH: Warsaw Stock Exchange) notifies that for January 2019 the Company recorded an increase of sales revenues of 1% compared to the same month of 2018, including 15% decrease of domestic sales and an increase of 13% of export sales.